Aston Particle Technologies
1 known investors
Aston Particle Technologies develops formulation solutions for small molecule and biological APIs using its patented isothermal dry particle coating (iDPC) technology, which layers particles without heat, solvents, or mechanical mixing aids. The company offers formulation and process development, material characterisation, and scalable manufacturing support for inhalational, biological, and oral solid dose medicines, serving pharmaceutical and biotech customers from pre-clinical to early phase I/II production.
BiotechDeep TechNew Materials
Investors · 1
Frequently asked questions
- What does Aston Particle Technologies do?
- Aston Particle Technologies develops formulation solutions for small molecule and biological APIs using its patented isothermal dry particle coating (iDPC) technology, which layers particles without heat, solvents, or mechanical mixing aids. The company offers formulation and process development, material characterisation, and scalable manufacturing support for inhalational, biological, and oral solid dose medicines, serving pharmaceutical and biotech customers from pre-clinical to early phase I/II production.
- Who are Aston Particle Technologies's investors?
- Aston Particle Technologies's investors include DSW Ventures.